| Year |
Citation |
Score |
| 1998 |
COCHRANE CG, WEIGLE WO, DIXON FJ. The role of polymorphonuclear leukocytes in the initiation and cessation of the Arthus vasculitis. The Journal of Experimental Medicine. 110: 481-94. PMID 13810816 DOI: 10.1084/Jem.110.3.481 |
0.523 |
|
| 1998 |
COCHRANE CG, WEIGLE WO, DIXON FJ. Factors responsible for decline of inflammation in Arthus hypersensitivity vasculitis. Proceedings of the Society For Experimental Biology and Medicine. Society For Experimental Biology and Medicine (New York, N.Y.). 101: 695-9. PMID 13810815 DOI: 10.3181/00379727-101-25065 |
0.52 |
|
| 1997 |
Quehenberger O, Pan ZK, Prossnitz ER, Cavanagh SL, Cochrane CG, Ye RD. Identification of an N-formyl peptide receptor ligand binding domain by a gain-of-function approach Biochemical and Biophysical Research Communications. 238: 377-381. PMID 9299516 DOI: 10.1006/Bbrc.1997.7298 |
0.507 |
|
| 1996 |
COCHRANE CG, UNANUE ER, DIXON FJ. A ROLE OF POLYMORPHONUCLEAR LEUKOCYTES AND COMPLEMENT IN NEPHROTOXIC NEPHRITIS. The Journal of Experimental Medicine. 122: 99-116. PMID 14330416 DOI: 10.1084/Jem.122.1.99 |
0.502 |
|
| 1993 |
Schreiber RE, Prossnitz ER, Ye RD, Cochrane CG, Jesaitis AJ, Bokoch GM. Reconstitution of recombinant N-formyl chemotactic peptide receptor with G protein Journal of Leukocyte Biology. 53: 470-474. PMID 8482927 DOI: 10.1002/Jlb.53.4.470 |
0.528 |
|
| 1993 |
Prossnitz ER, Quehenberger O, Cochrane CG, Ye RD. The role of the third intracellular loop of the neutrophil N-formyl peptide receptor in G protein coupling. The Biochemical Journal. 294: 581-7. PMID 8373373 DOI: 10.1042/Bj2940581 |
0.52 |
|
| 1992 |
Ye RD, Cavanagh SL, Quehenberger O, Prossnitz ER, Cochrane CG. Isolation of a cDNA that encodes a novel granulocyte N-formyl peptide receptor Biochemical and Biophysical Research Communications. 184: 582-589. PMID 1374236 DOI: 10.1016/0006-291X(92)90629-Y |
0.529 |
|
| 1991 |
Cochrane CG. Mechanisms of oxidant injury of cells. Molecular Aspects of Medicine. 12: 137-147. PMID 2072822 DOI: 10.1016/0098-2997(91)90009-B |
0.308 |
|
| 1991 |
Cochrane CG. Cellular injury by oxidants The American Journal of Medicine. 91: 177-188. PMID 1928208 DOI: 10.1016/0002-9343(91)90280-B |
0.304 |
|
| 1991 |
Revak SD, Merritt TA, Hallman M, Heldt G, La Polla RJ, Hoey K, Houghten RA, Cochrane CG. The use of synthetic peptides in the formation of biophysically and biologically active pulmonary surfactants. Pediatric Research. 29: 460-5. PMID 1896249 DOI: 10.1203/00006450-199105010-00010 |
0.303 |
|
| 1991 |
Prossnitz ER, Quehenberger O, Cochrane CG, Ye RD. Transmembrane signalling by the N-formyl peptide receptor in stably transfected fibroblasts. Biochemical and Biophysical Research Communications. 179: 471-6. PMID 1883372 DOI: 10.1016/0006-291X(91)91394-R |
0.532 |
|
| 1991 |
Ye RD, Prossnitz ER, Zou AH, Cochrane CG. Characterization of a human cDNA that encodes a functional receptor for platelet activating factor. Biochemical and Biophysical Research Communications. 180: 105-11. PMID 1656963 DOI: 10.1016/S0006-291X(05)81261-6 |
0.537 |
|
| 1990 |
Schraufstätter IU, Browne K, Harris A, Hyslop PA, Jackson JH, Quehenberger O, Cochrane CG. Mechanisms of hypochlorite injury of target cells. The Journal of Clinical Investigation. 85: 554-62. PMID 2153710 DOI: 10.1172/Jci114472 |
0.335 |
|
| 1989 |
Christiansen SC, Zuraw BL, Proud D, Cochrane CG. Inhibition of human bronchial kallikrein in asthma. The American Review of Respiratory Disease. 139: 1125-31. PMID 2785358 DOI: 10.1164/Ajrccm/139.5.1125 |
0.302 |
|
| 1988 |
Peters JH, Ginsberg MH, Case CM, Cochrane CG. Release of soluble fibronectin containing an extra type III domain (ED1) during acute pulmonary injury mediated by oxidants or leukocytes in vivo American Review of Respiratory Disease. 138: 167-174. PMID 3202394 DOI: 10.1164/Ajrccm/138.1.167 |
0.319 |
|
| 1988 |
Schraufstätter IU, Hyslop PA, Jackson J, Cochrane CG. Cellular Targets of H 2 O 2 and HOCl Induced Injury Basic Life Sciences. 49: 833-837. PMID 2855006 DOI: 10.1007/978-1-4684-5568-7_134 |
0.311 |
|
| 1988 |
Cochrane CG. Alpha-1-proteinase inhibitor in inflammatory states of humans and laboratory animals The American Journal of Medicine. 84: 75-79. DOI: 10.1016/S0002-9343(88)80074-3 |
0.303 |
|
| 1987 |
Christiansen SC, Proud D, Cochrane CG. Detection of tissue kallikrein in the bronchoalveolar lavage fluid of asthmatic subjects. The Journal of Clinical Investigation. 79: 188-97. PMID 3540008 DOI: 10.1172/Jci112782 |
0.338 |
|
| 1987 |
Schraufstätter IU, Hyslop PA, Jackson J, Revak SD, Cochrane CG. Biochemical events associated with pulmonary failure in shock and trauma. Journal of Burn Care & Rehabilitation. 8: 536-542. DOI: 10.1097/00004630-198708060-00016 |
0.309 |
|
| 1986 |
Peters JH, Ginsberg MH, Bohl BP, Sklar LA, Cochrane CG. Intravascular release of intact cellular fibronectin during oxidant-induced injury of the in vitro perfused rabbit lung Journal of Clinical Investigation. 78: 1596-1603. PMID 3023447 DOI: 10.1172/Jci112752 |
0.337 |
|
| 1986 |
Schraufstatter IU, Hyslop PA, Hinshaw DB, Spragg RG, Sklar LA, Cochrane CG. Hydrogen peroxide-induced injury of cells and its prevention by inhibitors of poly(ADP-ribose) polymerase. Proceedings of the National Academy of Sciences of the United States of America. 83: 4908-12. PMID 2941760 DOI: 10.1073/Pnas.83.13.4908 |
0.32 |
|
| 1986 |
Schraufstatter IU, Hinshaw DB, Hyslop PA, Spragg RG, Cochrane CG. Oxidant injury of cells. DNA strand-breaks activate polyadenosine diphosphate-ribose polymerase and lead to depletion of nicotinamide adenine dinucleotide. Journal of Clinical Investigation. 77: 1312-1320. PMID 2937805 DOI: 10.1172/Jci112436 |
0.305 |
|
| 1985 |
Schraufstatter IU, Hinshaw DB, Hyslop PA, Spragg RG, Cochrane CG. Glutathione cycle activity and pyridine nucleotide levels in oxidant-induced injury of cells. Journal of Clinical Investigation. 76: 1131-1139. PMID 3840176 DOI: 10.1172/Jci112068 |
0.317 |
|
| 1985 |
Jesaitis AJ, Tolley JO, Painter RG, Sklar LA, Cochrane CG. Membrane-cytoskeleton interactions and the regulation of chemotactic peptide-induced activation of human granulocytes: The effects of dihydrocytochalasin B Journal of Cellular Biochemistry. 27: 241-253. PMID 3838753 DOI: 10.1002/Jcb.240270306 |
0.345 |
|
| 1985 |
Revak SD, Rice CL, Schraufstätter IU, Halsey WA, Bohl BP, Clancy RM, Cochrane CG. Experimental pulmonary inflammatory injury in the monkey. The Journal of Clinical Investigation. 76: 1182-92. PMID 2995448 DOI: 10.1172/Jci112074 |
0.335 |
|
| 1985 |
Cochrane CG, Schraufstätter IU, Hinshaw DB, Hyslop PA, Spragg RG, Sklar LA. Atp In Oxidant-Induced Tissue Injury: 35 Pediatric Research. 19: 749-749. DOI: 10.1203/00006450-198507000-00055 |
0.303 |
|
| 1984 |
Schraufstätter IU, Revak SD, Cochrane CG. Proteases and oxidants in experimental pulmonary inflammatory injury. Journal of Clinical Investigation. 73: 1175-1184. PMID 6368592 DOI: 10.1172/Jci111303 |
0.339 |
|
| 1984 |
Jesaitis AJ, Naemura JR, Sklar LA, Cochrane CG, Painter RG. Rapid modulation of N-formyl chemotactic peptide receptors on the surface of human granulocytes: Formation of high-affinity ligand-receptor complexes in transient association with cytoskeleton Journal of Cell Biology. 98: 1378-1387. PMID 6325470 DOI: 10.1083/Jcb.98.4.1378 |
0.317 |
|
| 1984 |
Hyslop PA, Oades ZG, Jesaitis AJ, Painter RG, Cochrane CG, Sklar LA. Evidence for N-formyl chemotactic peptide-stimulated GTPase activity in human neutrophil homogenates Febs Letters. 166: 165-169. PMID 6141069 DOI: 10.1016/0014-5793(84)80065-4 |
0.338 |
|
| 1984 |
Hojima Y, Cochrane C, Wiggins R, Austen K, Stevens R. In vitro activation of the contact (Hageman factor) system of plasma by heparin and chondroitin sulfate E. Blood. 63: 1453-1459. DOI: 10.1182/Blood.V63.6.1453.1453 |
0.354 |
|
| 1983 |
Meier HL, Kaplan AP, Lichtenstein LM, Revak S, Cochrane CG, Newball HH. Anaphylactic release of a prekallikrein activator from human lung in vitro. Journal of Clinical Investigation. 72: 574-581. PMID 6192147 DOI: 10.1172/Jci111005 |
0.333 |
|
| 1982 |
Mcguire WW, Spragg RG, Cohen AB, Cochrane CG. Studies on the Pathogenesis of the Adult Respiratory Distress Syndrome Journal of Clinical Investigation. 69: 543-553. PMID 7037851 DOI: 10.1172/Jci110480 |
0.316 |
|
| 1982 |
Painter RG, Schmitt M, Jesaitis AJ, Sklar LA, Preissner K, Cochrane CG. Photoaffinity labeling of the N-formyl peptide receptor of human polymorphonuclear leukocytes Journal of Cellular Biochemistry. 20: 203-214. PMID 6302117 DOI: 10.1002/Jcb.240200211 |
0.325 |
|
| 1982 |
Sklar LA, Jesaitis AJ, Painter RG, Cochrane CG. Ligand/receptor internalization: A spectroscopic analysis and a comparison of ligand binding, cellular response, and internalization by human neutrophils Journal of Cellular Biochemistry. 20: 193-202. PMID 6302116 DOI: 10.1002/Jcb.240200210 |
0.305 |
|
| 1982 |
Jesaitis AJ, Naemura JR, Painter RG, Schmitt M, Sklar LA, Cochrane CG. The fate of the N-formyl-chemotactic peptide receptor in stimulated human granulocytes: Subcellular fractionation studies Journal of Cellular Biochemistry. 20: 177-191. PMID 6302115 DOI: 10.1002/Jcb.240200209 |
0.322 |
|
| 1982 |
Cochrane CG, Griffin JH. The biochemistry and pathophysiology of the contact system of plasma. Advances in Immunology. 33: 241-306. PMID 6182767 DOI: 10.1016/S0065-2776(08)60837-8 |
0.305 |
|
| 1982 |
Jesaitis AJ, Naemura JR, Painter RG, Sklar LA, Cochrane CG. Intracellular localization of N-formyl chemotactic receptor and Mg2+ dependent ATPase in human granulocytes Bba - General Subjects. 719: 556-568. PMID 6129903 DOI: 10.1016/0304-4165(82)90246-X |
0.306 |
|
| 1981 |
Sklar LA, Oades ZG, Jesaitis AJ, Painter RG, Cochrane CG. Fluoresceinated chemotactic peptide and high-affinity antifluorescein antibody as a probe of the temporal characteristics of neutrophil stimulation Proceedings of the National Academy of Sciences of the United States of America. 78: 7540-7544. PMID 7038681 DOI: 10.1073/Pnas.78.12.7540 |
0.316 |
|
| 1981 |
Wiggins RC, Cochrane CG. Immune-Complex-Mediated Biologic Effects The New England Journal of Medicine. 304: 518-520. PMID 6450327 DOI: 10.1056/Nejm198102263040904 |
0.304 |
|
| 1980 |
Curd JG, Prograis LJ, Cochrane CG. Detection of active kallikrein in induced blister fluids of hereditary angioedema patients. Journal of Experimental Medicine. 152: 742-747. PMID 6902743 DOI: 10.1084/Jem.152.3.742 |
0.335 |
|
| 1980 |
Wiggins RC, Loskutoff DJ, Cochrane CG, Griffin JH, Edgington TS. Activation of rabbit Hageman factor by homogenates of cultured rabbit endothelial cells. The Journal of Clinical Investigation. 65: 197-206. PMID 6444222 DOI: 10.1172/Jci109651 |
0.551 |
|
| 1979 |
Wiggins RC, Cochrane CG, Griffin JH. Rabbit blood coagulation factor XI. Mechanism of activation of rabbit Hageman factor (factor XII). Thrombosis Research. 15: 487-95. PMID 494157 DOI: 10.1016/0049-3848(79)90154-3 |
0.328 |
|
| 1979 |
Wiggins RC, Cochrane CG, Griffin JH. Rabbit blood coagulation factor XI. Purification and properties. Thrombosis Research. 15: 475-86. PMID 494156 DOI: 10.1016/0049-3848(79)90153-1 |
0.313 |
|
| 1979 |
Cochrane CG, Griffin JH. Molecular assembly in the contact phase of the Hageman factor system. The American Journal of Medicine. 67: 657-64. PMID 386794 DOI: 10.1016/0002-9343(79)90253-5 |
0.307 |
|
| 1978 |
Revak SD, Cochrane CG, Bouma BN, Griffin JH. Surface and fluid phase activities of two forms of activated Hageman factor produced during contact activation of plasma. The Journal of Experimental Medicine. 147: 719-29. PMID 632748 DOI: 10.1084/Jem.147.3.719 |
0.302 |
|
| 1978 |
Wiggins RC, Bouma BN, Cochrane CG, Griffin JH. Role of high-molecular-weight kininogen in surface-binding and activation of coagulation Factor XI and prekallikrein. Proceedings of the National Academy of Sciences of the United States of America. 74: 4636-40. PMID 270705 DOI: 10.1073/Pnas.74.10.4636 |
0.32 |
|
| 1978 |
Cochrane CG. Mediating systems in inflammatory disease. Journal of Investigative Dermatology. 71: 40-48. PMID 150452 DOI: 10.1111/1523-1747.Ep12543931 |
0.306 |
|
| 1977 |
Revak SD, Cochrane CG, Griffin JH. The binding and cleavage characteristics of human Hageman factor during contact activation. A comparison of normal plasma with plasmas deficient in factor XI, prekallikrein, or high molecular weight kininogen. The Journal of Clinical Investigation. 59: 1167-75. PMID 864009 DOI: 10.1172/Jci108741 |
0.318 |
|
| 1977 |
Cochrane CG. Role of granulocytes in immune complex-induced tissue injuries. Inflammation. 2: 319-333. PMID 154471 DOI: 10.1007/Bf00921011 |
0.346 |
|
| 1976 |
Griffin JH, Cochrane CG. Mechanisms for the involvement of high molecular weight kininogen in surface-dependent reactions of Hageman factor. Proceedings of the National Academy of Sciences of the United States of America. 73: 2554-8. PMID 1066663 DOI: 10.1073/Pnas.73.8.2554 |
0.316 |
|
| 1976 |
Griffin JH, Cochrane CG. [7] Human factor XII (Hageman factor) Methods in Enzymology. 45: 56-65. PMID 1012017 DOI: 10.1016/S0076-6879(76)45009-7 |
0.322 |
|
| 1976 |
Morrison DC, Henson PM, Roser JF, Cochrane CG. Two Independent Recognition Sites for the Initiation of Histamine Release from Mast Cells Leukocyte Membrane Determinants Regulating Immune Reactivity. 551-562. DOI: 10.1016/B978-0-12-233750-5.50105-6 |
0.331 |
|
| 1975 |
Morrison DC, Roser JF, Cochrane CG, Henson PM. Two distinct mechanisms for the initiation of mast cell Degranulation International Archives of Allergy and Immunology. 49: 172-178. PMID 166931 DOI: 10.1159/000231392 |
0.319 |
|
| 1974 |
Morrison DC, Cochrane CG. Direct evidence for Hageman factor (factor XII) activation by bacterial lipopolysaccharides (endotoxins) Journal of Experimental Medicine. 140: 797-811. PMID 4378413 DOI: 10.1084/Jem.140.3.797 |
0.311 |
|
| 1974 |
Cochrane CG, Revak SD, Wuepper KD, Johnston A, Morrison DC, Ulevitch R. Soluble mediators of injury of the microvasculature; Hageman factor and the kinin forming, intrinsic clotting and the fibrinolytic systems. Microvascular Research. 8: 112-121. PMID 4278273 DOI: 10.1016/0026-2862(74)90069-7 |
0.325 |
|
| 1974 |
Revak SD, Cochrane CG, Johnston AR, Hugli TE. Structural Changes Accompanying Enzymatic Activation of Human Hageman Factor Journal of Clinical Investigation. 54: 619-627. PMID 4277669 DOI: 10.1172/Jci107799 |
0.327 |
|
| 1973 |
Cochrane CG, Revak SD, Wuepper KD. Activation Of Hageman Factor In Solid And Fluid Phases A Critical Role Of Kallikrein Journal of Experimental Medicine. 138: 1564-1583. PMID 4271629 DOI: 10.1084/Jem.138.6.1564 |
0.343 |
|
| 1973 |
Benveniste J, Henson PM, Cochrane CG. Leukocyte-dependent histamine release from rabbit platelets. The role of IgE, basophils, and a platelet-activating factor. The Journal of Experimental Medicine. 136: 1356-77. PMID 4118412 DOI: 10.1084/Jem.136.6.1356 |
0.325 |
|
| 1972 |
Cochrane CG, Wuepper KD, Aiken BS, Revak SD, Spiegelberg HL. The Interaction of Hageman Factor and Immune Complexes Journal of Clinical Investigation. 51: 2736-2745. PMID 5056666 DOI: 10.1172/Jci107093 |
0.352 |
|
| 1972 |
DeShazo CV, Henson PM, Cochrane CG. Acute immunologic arthritis in rabbits. The Journal of Clinical Investigation. 51: 50-7. PMID 4257028 DOI: 10.1172/Jci106796 |
0.333 |
|
| 1971 |
Levine S, Cochrane CG, Carpenter CB, Behan PO. Allergic Encephalomyelitis: Effect of Complement Depletion with Cobra Venom Proceedings of the Society For Experimental Biology and Medicine. 138: 285-289. PMID 5001508 DOI: 10.3181/00379727-138-35880 |
0.3 |
|
| 1971 |
Henson PM, Cochrane CG. Acute immune complex disease in rabbits. The role of complement and of a leukocyte-dependent release of vasoactive amines from platelets. The Journal of Experimental Medicine. 133: 554-71. PMID 4106804 DOI: 10.1084/Jem.133.3.554 |
0.309 |
|
| 1971 |
Cochrane CG, Wuepper KD. The first component of the kinin-forming system in human and rabbit plasma. Its relationship to clotting factor XII (Hageman Factor). Journal of Experimental Medicine. 134: 986-1004. PMID 4106492 DOI: 10.1084/Jem.134.4.986 |
0.339 |
|
| 1971 |
Cochrane CG. Mechanisms involved in the deposition of immune complexes in tissues. Journal of Experimental Medicine. 134: 75-89. DOI: 10.1084/Jem.134.3.75 |
0.312 |
|
| 1969 |
Henson PM, Cochrane CG. Immunological induction of increased vascular permeability. I. A rabbit passive cutaneous anaphylactic reaction requiring complement, platelets, and neutrophils. The Journal of Experimental Medicine. 129: 153-65. PMID 5774114 DOI: 10.1084/Jem.129.1.153 |
0.32 |
|
| 1969 |
Henson PM, Cochrane CG. Immunological induction of increased vascular permeability. II. Two mechanisms of histamine release from rabbit platelets involving complement. The Journal of Experimental Medicine. 129: 167-84. PMID 4178112 DOI: 10.1084/Jem.129.1.167 |
0.321 |
|
| 1968 |
Kniker WT, Cochrane CG. The Localization Of Circulating Immune Complexes In Experimental Serum Sickness : The Role Of Vasoactive Amines And Hydrodynamic Forces Journal of Experimental Medicine. 127: 119-136. PMID 4864670 DOI: 10.1084/Jem.127.1.119 |
0.304 |
|
| 1968 |
Cochrane CG. Immunologic tissue injury mediated by neutrophilic leukocytes. Advances in Immunology. 9: 97-162. PMID 4236490 DOI: 10.1016/S0065-2776(08)60442-3 |
0.341 |
|
| 1965 |
Ward PA, Cochrane CG, Mueller-Eberhard HJ. The Role Of Serum Complement In Chemotaxis Of Leukocytes In Vitro Journal of Experimental Medicine. 122: 327-346. PMID 14316948 DOI: 10.1084/Jem.122.2.327 |
0.329 |
|
| 1965 |
Ward PA, Cochrane CG. Bound Complement And Immunologic Injury Of Blood Vessels Journal of Experimental Medicine. 121: 215-234. PMID 14264268 DOI: 10.1084/Jem.121.2.215 |
0.318 |
|
| 1963 |
Cochrane CG. Studies On The Localization Of Circulating Antigen-Antibody Complexes And Other Macromolecules In Vessels. Ii. Pathogenetic And Pharmacodynamic Studies. Journal of Experimental Medicine. 118: 503-513. PMID 14067902 DOI: 10.1084/Jem.118.4.503 |
0.313 |
|
| 1963 |
Cochrane CG. Studies On The Localization Of Circulating Antigen-Antibody Complexes And Other Macromolecules In Vessels. I. Structural Studies. Journal of Experimental Medicine. 118: 489-502. PMID 14067901 DOI: 10.1084/Jem.118.4.489 |
0.316 |
|
| 1963 |
Cochrane CG, Dixon FJ. Antibody Production by Transferred Cells1 Advances in Immunology. 2: 205-239. DOI: 10.1016/S0065-2776(08)60114-5 |
0.5 |
|
| 1958 |
Cochrane CG, Weigle WO. The cutaneous reaction to soluble antigen-antibody complexes; a comparison with the Arthus phenomenon. Journal of Experimental Medicine. 108: 591-604. PMID 13587844 DOI: 10.1084/Jem.108.5.591 |
0.316 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2015 |
Cochrane CG, Spragg RG, Revak SD, Cohen AB, McGuire WW. The Presence of Neutrophil Elastase and Evidence of Oxidation Activity in Bronchoalveolar Lavage Fluid of Patients with Adult Respiratory Distress Syndrome1,2 The American Review of Respiratory Disease. 127. PMID 6550478 DOI: 10.1164/Arrd.1983.127.2P2.S25 |
0.298 |
|
| 2005 |
Cochrane CG. Pulmonary surfactant in allergic inflammation: new insights into the molecular mechanisms of surfactant function. American Journal of Physiology. Lung Cellular and Molecular Physiology. 288: L608-9. PMID 15757953 DOI: 10.1152/Ajplung.00434.2004 |
0.297 |
|
| 1981 |
Newball HH, Meier HL, Kaplan AP, Revak SD, Cochrane CG, Lichtenstein LM. Activation of the Hageman Factor-Dependent Systems during IgE-Mediated Reactions of the Human Lung International Archives of Allergy and Immunology. 66: 165-167. DOI: 10.1159/000232894 |
0.297 |
|
| 1980 |
Ulevitch RJ, Cochrane CG, Johnston AR. Rabbit prekallikrein. Purification, biochemical characterization, and mechanism of activation. Inflammation. 4: 9-25. PMID 6901516 DOI: 10.1007/Bf00914099 |
0.296 |
|
| 1980 |
Cochrane CG, Revak SD. The participation of high molecular weight kininogen in hypotensive shock and intravascular coagulation Clinical Immunology and Immunopathology. 15: 367-374. PMID 6154553 DOI: 10.1016/0090-1229(80)90048-3 |
0.296 |
|
| 1988 |
Yamamoto T, Kozono K, Kambara T, Cochrane CG. The Hageman factor-dependent system in the vascular permeability reaction Biochimica Et Biophysica Acta. 966: 196-206. PMID 3401504 DOI: 10.1016/0304-4165(88)90112-2 |
0.295 |
|
| 1996 |
Manalo E, Merritt TA, Kheiter A, Amirkhanian J, Cochrane C. Comparative effects of some serum components and proteolytic products of fibrinogen on surface tension-lowering abilities of beractant and a synthetic peptide containing surfactant KL4. Pediatric Research. 39: 947-952. PMID 8725253 DOI: 10.1203/00006450-199606000-00004 |
0.295 |
|
| 1980 |
Cochrane CG, Revak SD. Dissemination of contact activation in plasma by plasma kallikrein. Journal of Experimental Medicine. 152: 608-619. PMID 6902742 DOI: 10.1084/Jem.152.3.608 |
0.294 |
|
| 1975 |
Morrison DC, Roser JF, Henson PM, Cochrane CG. Isolation and characterization of a noncytotoxic mast-cell activator from cobra venom Inflammation. 1: 103-115. DOI: 10.1007/Bf00918063 |
0.293 |
|
| 1974 |
Ulevitch RJ, Letchford D, Cochrane CG. A direct enzymatic assay for the esterolytic activity of activated Hageman factor. Thrombosis Et Diathesis Haemorrhagica. 31: 30. DOI: 10.1055/S-0038-1649143 |
0.291 |
|
| 1988 |
Parkos CA, Allen RA, Cochrane CG, Jesaitis AJ. The quaternary structure of the plasma membrane b-type cytochrome of human granulocytes Bba - Bioenergetics. 932: 71-83. PMID 3337799 DOI: 10.1016/0005-2728(88)90140-5 |
0.29 |
|
| 1978 |
Lennon VA, Seybold ME, Lindstrom JM, Cochrane C, Ulevitch R. Role of complement in the pathogenesis of experimental autoimmune myasthenia gravis. The Journal of Experimental Medicine. 147: 973-83. PMID 206648 DOI: 10.1084/Jem.147.4.973 |
0.29 |
|
| 1987 |
Smith RM, Spragg RG, Moser KM, Cochrane CG, McCarren JP. Pulmonary penetration of alpha 1-proteinase inhibitor administered parenterally to dogs. The American Review of Respiratory Disease. 136: 1391-6. PMID 3120632 DOI: 10.1164/Ajrccm/136.6.1391 |
0.288 |
|
| 1968 |
Ranadive NS, Cochrane CG. Isolation And Characterization Of Permeability Factors From Rabbit Neutrophils Journal of Experimental Medicine. 128: 605-622. PMID 4175322 DOI: 10.1084/Jem.128.4.605 |
0.287 |
|
| 1976 |
Revak SD, Cochrane CG. The relationship of structure and function in human Hageman factor. The association of enzymatic and binding activities with separate regions of the molecule. Journal of Clinical Investigation. 57: 852-860. PMID 947956 DOI: 10.1172/Jci108361 |
0.287 |
|
| 1964 |
Cochrane CG. Cutaneous Anaphylactic Reactions With Antibodies Of Different Qualities. Experimental Biology and Medicine. 116: 475-480. PMID 14193378 DOI: 10.3181/00379727-116-29283 |
0.286 |
|
| 1977 |
Ulevitch RJ, Cochrane CG. Complement-dependent hemodynamic and hematologic changes in the rabbit. Inflammation. 2: 199-216. PMID 367962 DOI: 10.1007/Bf00917596 |
0.285 |
|
| 1988 |
Revak SD, Merritt TA, Degryse E, Stefani L, Courtney M, Hallman M, Cochrane CG. Use of human surfactant low molecular weight apoproteins in the reconstitution of surfactant biologic activity. Journal of Clinical Investigation. 81: 826-833. PMID 3343343 DOI: 10.1172/Jci113391 |
0.284 |
|
| 1986 |
Yamamoto T, Kozono K, Tsuruta J, Cochrane CG, Kambara T. Hageman factor dependent pathway in local vascular permeability enhancement. Advances in Experimental Medicine and Biology. 45-52. PMID 3812107 DOI: 10.1007/978-1-4757-0154-8_6 |
0.283 |
|
| 1988 |
Schraufstatter IU, Halsey WA, Hyslop PA, Cochrane CG. [29] In vitro models for the study of oxidant-induced injury of cells in inflammation Methods in Enzymology. 163: 328-339. PMID 3237081 DOI: 10.1016/0076-6879(88)63031-X |
0.283 |
|
| 1994 |
Cochrane CG, Revak SD. Protein-Phospholipid Interactions in Pulmonary Surfactant: The Parker B. Francis Lectureship Chest. 105: 57. PMID 8131614 DOI: 10.1378/Chest.105.3_Supplement.57S |
0.282 |
|
| 1966 |
Cochrane CG, Aikin BS. Polymorphonuclear Leukocytes In Immunologic Reactions : The Destruction Of Vascular Basement Membrane In Vivo And In Vitro Journal of Experimental Medicine. 124: 733-752. PMID 4162449 DOI: 10.1084/Jem.124.4.733 |
0.281 |
|
| 1992 |
Christiansen SC, Proud D, Sarnoff RB, Juergens U, Cochrane CG, Zuraw BL. Elevation of tissue kallikrein and kinin in the airways of asthmatic subjects after endobronchial allergen challenge. The American Review of Respiratory Disease. 145: 900-5. PMID 1554219 DOI: 10.1164/Ajrccm/145.4_Pt_1.900 |
0.281 |
|
| 1969 |
Bokisch VA, Müller-Eberhard HJ, Cochrane CG. Isolation of a fragment (C3a) of the third component of human complement containing anaphylatoxin and chemotactic activity and description of an anaphylatoxin inactivator of human serum. Journal of Experimental Medicine. 129: 1109-1130. PMID 5778786 DOI: 10.1084/Jem.129.5.1109 |
0.28 |
|
| 1968 |
Cochrane CG, Hawkins D. Studies On Circulating Immune Complexes Iii. Factors Governing The Ability Of Circulating Complexes To Localize In Blood Vessels Journal of Experimental Medicine. 127: 137-154. PMID 4169437 DOI: 10.1084/Jem.127.1.137 |
0.279 |
|
| 1968 |
Cochrane CG, Müller-Eberhard HJ. The Derivation Of Two Distinct Anaphylatoxin Activities From The Third And Fifth Components Of Human Complement Journal of Experimental Medicine. 127: 371-386. PMID 4383923 DOI: 10.1084/Jem.127.2.371 |
0.279 |
|
| 1986 |
Merritt TA, Hallman M, Holcomb K, Strayer D, Bloom B, Revak S, Cochrane CG. Human surfactant treatment of severe respiratory distress syndrome: pulmonary effluent indicators of lung inflammation. The Journal of Pediatrics. 108: 741-8. PMID 3486264 DOI: 10.1016/S0022-3476(86)81058-7 |
0.279 |
|
| 1985 |
Spragg RG, Hinshaw DB, Hyslop PA, Schraufstätter IU, Cochrane CG. Alterations in adenosine triphosphate and energy charge in cultured endothelial and P388D1 cells after oxidant injury. Journal of Clinical Investigation. 76: 1471-1476. PMID 2997279 DOI: 10.1172/Jci112126 |
0.278 |
|
| 1976 |
Ulevitch RJ, Cochrane CG, Henson PM, Morrison DC, Doe WF. Mediation systems in bacterial lipopolysaccharide-induced hypotension and disseminated intravascular coagulation. I. The role of complement. The Journal of Experimental Medicine. 142: 1570-90. PMID 1104750 DOI: 10.1084/Jem.142.6.1570 |
0.277 |
|
| 1996 |
Revak SD, Merritt TA, Cochrane CG, Heldt GP, Alberts MS, Anderson DW, Kheiter A. Efficacy of synthetic peptide-containing surfactant in the treatment of respiratory distress syndrome in preterm infant rhesus monkeys. Pediatric Research. 39: 715-24. PMID 8848350 DOI: 10.1203/00006450-199604000-00025 |
0.277 |
|
| 1998 |
Cochrane CG, Revak SD, Merritt TA, Schraufstätter IU, Hoch RC, Henderson C, Andersson S, Takamori H, Oades ZG. Bronchoalveolar Lavage with KL4-Surfactant in Models of Meconium Aspiration Syndrome Pediatric Research. 44: 705-715. PMID 9803452 DOI: 10.1203/00006450-199811000-00013 |
0.277 |
|
| 1996 |
Cochrane CG, Revak SD, Merritt TA, Heldt GP, Hallman M, Cunningham MD, Easa D, Pramanik A, Edwards DK, Alberts MS. The efficacy and safety of KL4-surfactant in preterm infants with respiratory distress syndrome. American Journal of Respiratory and Critical Care Medicine. 153: 404-10. PMID 8542150 DOI: 10.1164/Ajrccm.153.1.8542150 |
0.277 |
|
| 1965 |
Kniker WT, Cochrane CG. Pathogenic Factors In Vascular Lesions Of Experimental Serum Sickness Journal of Experimental Medicine. 122: 83-98. PMID 14325476 DOI: 10.1084/Jem.122.1.83 |
0.276 |
|
| 1973 |
Cochrane CG, Koffler D. Immune complex disease in experimental animals and man. Advances in Immunology. 16: 185-264. PMID 4599389 DOI: 10.1016/S0065-2776(08)60298-9 |
0.275 |
|
| 2000 |
Pan ZK, Chen LY, Cochrane CG, Zuraw BL. fMet-Leu-Phe stimulates proinflammatory cytokine gene expression in human peripheral blood monocytes: The role of phosphatidylinositol 3-kinase Journal of Immunology. 164: 404-411. PMID 10605036 DOI: 10.4049/Jimmunol.164.1.404 |
0.274 |
|
| 1972 |
Wuepper KD, Cochrane CG. Effect of plasma kallikrein on coagulation in vitro. Experimental Biology and Medicine. 141: 271-276. PMID 4673303 DOI: 10.3181/00379727-141-36757 |
0.272 |
|
| 1987 |
Parkos CA, Allen RA, Cochrane CG, Jesaitis AJ. Purified cytochrome b from human granulocyte plasma membrane is comprised of two polypeptides with relative molecular weights of 91,000 and 22,000 Journal of Clinical Investigation. 80: 732-742. PMID 3305576 DOI: 10.1172/Jci113128 |
0.272 |
|
| 1983 |
Cochrane CG, Spragg R, Revak SD. Pathogenesis of the adult respiratory distress syndrome. Evidence of oxidant activity in bronchoalveolar lavage fluid. Journal of Clinical Investigation. 71: 754-761. PMID 6600748 DOI: 10.1172/Jci110823 |
0.27 |
|
| 1991 |
Vincent JS, Revak SD, Cochrane CG, Levin IW. Raman spectroscopic studies of model human pulmonary surfactant systems: phospholipid interactions with peptide paradigms for the surfactant protein SP-B. Biochemistry. 30: 8395-401. PMID 1883825 DOI: 10.1021/Bi00098A017 |
0.27 |
|
| 1968 |
Cochrane CG. The role of immune complexes and complement in tissue injury. Journal of Allergy. 42: 113-129. PMID 4234077 DOI: 10.1016/0021-8707(68)90085-3 |
0.268 |
|
| 1975 |
Cochrane CG. The Participation of Cells in the Inflammatory Injury of tissue Journal of Investigative Dermatology. 64: 301-306. PMID 49380 DOI: 10.1111/1523-1747.Ep12512255 |
0.267 |
|
| 1983 |
Merritt TA, Cochrane CG, Holcomb K, Bohl B, Hallman M, Strayer D, Edwards DK, Gluck L. Elastase and alpha 1-proteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome. Role of inflammation in the pathogenesis of bronchopulmonary dysplasia. The Journal of Clinical Investigation. 72: 656-66. PMID 6603478 DOI: 10.1172/Jci111015 |
0.266 |
|
| 1996 |
Hoch RC, Schraufstätter IU, Cochrane CG. In vivo, in vitro, and molecular aspects of interleukin-8 and the interleukin-8 receptors. Journal of Laboratory and Clinical Medicine. 128: 134-145. PMID 8765209 DOI: 10.1016/S0022-2143(96)90005-0 |
0.266 |
|
| 1976 |
Russell SW, Gillespie GY, Hansen CB, Cochrane CG. Inflammatory cells in solid murine neoplasms. II. Cell types found throughout the course of Moloney sarcoma regression or progression. International Journal of Cancer. 18: 331-8. PMID 1085289 DOI: 10.1002/Ijc.2910180310 |
0.266 |
|
| 1987 |
Allen RA, Jesaitis AJ, Cochrane CG. Photoaffinity labelling of N-formyl peptide receptors Pharmacology and Therapeutics. 33: 333-348. PMID 3310037 DOI: 10.1016/0163-7258(87)90070-2 |
0.264 |
|
| 1983 |
Hojima Y, Pisano JJ, Cochrane CG. Survey of plant inhibitors of polymorphonuclear leukocyte elastase, pancreatic elastase, cathepsin G, cathepsin B, hageman factor fragments, and other serine proteinases Biochemical Pharmacology. 32: 985-990. PMID 6340694 DOI: 10.1016/0006-2952(83)90615-9 |
0.264 |
|
| 1993 |
Maly FE, Schuerer-Maly CC, Quilliam L, Cochrane CG, Newburger PE, Curnutte JT, Gifford M, Dinauer MC. Restitution of superoxide generation in autosomal cytochrome-negative chronic granulomatous disease (A22(0) CGD)-derived B lymphocyte cell lines by transfection with p22phax cDNA. The Journal of Experimental Medicine. 178: 2047-53. PMID 8245781 DOI: 10.1084/Jem.178.6.2047 |
0.263 |
|
| 1991 |
Cochrane C, Revak S. Pulmonary surfactant protein B (SP-B): structure-function relationships. Science. 254: 566-568. PMID 1948032 DOI: 10.1126/Science.1948032 |
0.262 |
|
| 1959 |
YUILE CL, LUCAS FV, NEUBECKER RD, COCHRANE CG, WHIPPLE GH. Depletion of reserve protein from extravascular extracellular fluid; C14 labeling of plasma proteins in dogs after plasmapheresis. The Journal of Experimental Medicine. 109: 165-71. PMID 13620846 DOI: 10.1084/Jem.109.2.165 |
0.262 |
|
| 1983 |
Merritt TA, Cochrane CG, Hallman M, Holcomb KE, Strayer D, Mannino F, Edwards DK, Gluck L. Reduction of lung injury by human surfactant treatment in respiratory distress syndrome. Chest. 83: 27S-31S. PMID 6601570 DOI: 10.1378/Chest.83.5_Supplement.27S |
0.26 |
|
| 1998 |
Cochrane CG. Surfactant protein B and mimic peptides in the function of pulmonary surfactant Febs Letters. 430: 424-424. PMID 9688585 DOI: 10.1016/S0014-5793(98)00710-8 |
0.258 |
|
| 1978 |
Ulevitch RJ, Cochrane CG. Role of complement in lethal bacterial lipopolysaccharide-induced hypotensive and coagulative changes. Infection and Immunity. 19: 204-211. PMID 24001 DOI: 10.1128/Iai.19.1.204-211.1978 |
0.257 |
|
| 1983 |
Cochrane CG, Spragg RG, Revak SD, Schraufstatter I. Biochemical Factors in Pulmonary Inflammatory Disease Chest. 83: 67. PMID 6340987 DOI: 10.1378/Chest.83.5_Supplement.67S |
0.257 |
|
| 1988 |
Jackson JH, Cochrane CG. Leukocyte-induced tissue injury. Hematology-Oncology Clinics of North America. 2: 317-334. DOI: 10.1016/S0889-8588(18)30624-5 |
0.257 |
|
| 1988 |
Schraufstätter I, Hyslop PA, Jackson JH, Cochrane CG. Oxidant-induced DNA damage of target cells. The Journal of Clinical Investigation. 82: 1040-50. PMID 2843565 DOI: 10.1172/Jci113660 |
0.256 |
|
| 1983 |
Lasser EC, Lang JH, Curd JG, Cochrane CG, Lyon SG, Howard MM, Hamblin AE, Revak SD. The plasma contact system in atopic asthma The Journal of Allergy and Clinical Immunology. 72: 83-88. PMID 6189880 DOI: 10.1016/0091-6749(83)90056-8 |
0.254 |
|
| 1966 |
McKee WD, Cochrane CG, Farr RS. A clinical study of an unusual case of asthma associated with urticaria pigmentosa. Journal of Allergy. 37: 38-47. PMID 5216210 DOI: 10.1016/0021-8707(66)90108-0 |
0.254 |
|
| 1984 |
Saugstad OD, Hallman M, Abraham JL, Epstein B, Cochrane C, Gluck L. Hypoxanthine and oxygen induced lung injury: a possible basic mechanism of tissue damage? Pediatric Research. 18: 501-504. PMID 6610852 DOI: 10.1203/00006450-198406000-00002 |
0.253 |
|
| 1987 |
Hyslop PA, Hinshaw DB, Schraufstätter IU, Sklar LA, Spragg RG, Cochrane CG. Intracellular calcium homeostasis during hydrogen peroxide injury to cultured P388D1 cells. Journal of Cellular Physiology. 129: 356-66. PMID 3782310 DOI: 10.1002/Jcp.1041290314 |
0.25 |
|
| 1989 |
Jackson JH, Gajewski E, Schraufstatter IU, Hyslop PA, Fuciarelli AF, Cochrane CG, Dizdaroglu M. Damage to the bases in DNA induced by stimulated human neutrophils. The Journal of Clinical Investigation. 84: 1644-9. PMID 2553779 DOI: 10.1172/Jci114342 |
0.25 |
|
| 1987 |
Cochrane CG. The enhancement of inflammatory injury. The American Review of Respiratory Disease. 136: 1-2. PMID 3605824 DOI: 10.1164/Ajrccm/136.1.1 |
0.25 |
|
| 1975 |
Henson PM, Cochrane CG. The effect of complement depletion on experimental tissue injury. Annals of the New York Academy of Sciences. 256: 426-40. PMID 126034 DOI: 10.1111/J.1749-6632.1975.Tb36069.X |
0.248 |
|
| 1982 |
Curd JG, Yelvington M, Burridge N, Stimler NP, Gerard C, Prograis LJ, Cochrane CG, Müller-Eberhard HJ. Generation of bradykinin during incubation of hereditary angioedema plasma Molecular Immunology. 19: 1365. DOI: 10.1016/0161-5890(82)90035-9 |
0.241 |
|
| 1994 |
Jackson JH, Li JW, Buss JE, Der CJ, Cochrane CG. Polylysine domain of K-ras 4B protein is crucial for malignant transformation. Proceedings of the National Academy of Sciences of the United States of America. 91: 12730-4. PMID 7809111 DOI: 10.1073/Pnas.91.26.12730 |
0.239 |
|
| 1976 |
Ulevitch RJ, Morrison DC, Cochrane CG, Henson PM. Complement independent lipopolysaccharide (LPS) induced hypotension and disseminated intravascular coagulation: a correlation of LPS structure with in vivo and in vitro biological activities Advances in Experimental Medicine and Biology. 73: 339-349. PMID 793350 DOI: 10.1007/978-1-4684-3297-8_28 |
0.239 |
|
| 2002 |
Wiswell TE, Knight GR, Finer NN, Donn SM, Desai H, Walsh WF, Sekar KC, Bernstein G, Keszler M, Visser VE, Merritt TA, Mannino FL, Mastrioianni L, Marcy B, Revak SD, ... ... Cochrane CG, et al. A multicenter, randomized, controlled trial comparing Surfaxin (Lucinactant) lavage with standard care for treatment of meconium aspiration syndrome. Pediatrics. 109: 1081-7. PMID 12042546 DOI: 10.1542/Peds.109.6.1081 |
0.238 |
|
| 1979 |
Griffin JH, Cochrane CG. Recent advances in the understanding of contact activation reactions. Seminars in Thrombosis and Hemostasis. 5: 254-73. PMID 386517 DOI: 10.1055/S-0028-1087158 |
0.236 |
|
| 1990 |
Jackson JH, Cochrane CG, Bourne JR, Solski PA, Buss JE, Der CJ. Farnesol modification of Kirsten-ras exon 4B protein is essential for transformation. Proceedings of the National Academy of Sciences of the United States of America. 87: 3042-6. PMID 2183224 DOI: 10.1073/Pnas.87.8.3042 |
0.236 |
|
| 1999 |
Wiswell TE, Smith RM, Katz LB, Mastroianni L, Wong DY, Willms D, Heard S, Wilson M, Hite RD, Anzueto A, Revak SD, Cochrane CG. Bronchopulmonary segmental lavage with surfaxin (KL4-surfactant) for acute respiratory distress syndrome American Journal of Respiratory and Critical Care Medicine. 160: 1188-1195. PMID 10508806 DOI: 10.1164/Ajrccm.160.4.9808118 |
0.232 |
|
| 1985 |
Christiansen SC, Bohl B, Proud D, Simon R, Cochrane CG. 289 Kininogenase activity in bronchoalveolar lavage (BAL) fluids in asthma The Journal of Allergy and Clinical Immunology. 75: 177. DOI: 10.1016/0091-6749(85)90424-5 |
0.231 |
|
| 1976 |
Russell SW, Doe WF, Hoskins RG, Cochrane CG. Inflammatory cells in solid murine neoplasms. I. Tumor disaggregation and identification of constituent inflammatory cells. International Journal of Cancer. 18: 322-330. PMID 182647 DOI: 10.1002/Ijc.2910180309 |
0.231 |
|
| 1995 |
Schraufstätter IU, Ma M, Oades ZG, Barritt DS, Cochrane CG. The role of Tyr13 and Lys15 of interleukin-8 in the high affinity interaction with the interleukin-8 receptor type A. Journal of Biological Chemistry. 270: 10428-10431. PMID 7737976 DOI: 10.1074/Jbc.270.18.10428 |
0.229 |
|
| 1991 |
Schraufstatter IU, Cochrane CG. H2O2 Induced Cellular Dna Damage And Its Consequences Oxidative Damage & Repairchemical, Biological and Medical Aspects. 481-486. DOI: 10.1016/B978-0-08-041749-3.50089-9 |
0.225 |
|
| 1995 |
Hyslop PA, Hinshaw DB, Scraufstatter IU, Cochrane CG, Kunz S, Vosbeck K. Hydrogen peroxide as a potent bacteriostatic antibiotic: Implications for host defense Free Radical Biology and Medicine. 19: 31-37. PMID 7635356 DOI: 10.1016/0891-5849(95)00005-I |
0.224 |
|
| 1984 |
Cochrane CG. The role of complement in experimental disease models. Springer Seminars in Immunopathology. 7: 263-270. PMID 6238436 DOI: 10.1007/Bf01893023 |
0.223 |
|
| 1990 |
Schraufstätter IU, Cochrane CG. H2O2 induced cellular DNA damage and its metabolic consequences Free Radical Biology and Medicine. 9: 104. DOI: 10.1016/0891-5849(90)90542-Q |
0.218 |
|
| 1967 |
Cochrane CG. The Arthus phenomenon--a mechanism of tissue damage. Arthritis & Rheumatism. 10: 392-396. PMID 4227673 DOI: 10.1002/Art.1780100410 |
0.217 |
|
| 1999 |
Cochrane CG, Revak SD. Surfactant Lavage Treatment in a Model of Respiratory Distress Syndrome Chest. 116. PMID 10424605 DOI: 10.1378/Chest.116.Suppl_1.85S |
0.211 |
|
| 1974 |
Russell SW, Cochrane CG. The cellular events associated with regression and progression of murine (Moloney) sarcomas. International Journal of Cancer. 13: 54-63. PMID 4856384 DOI: 10.1002/Ijc.2910130107 |
0.208 |
|
| 1995 |
Merritt TA, Kheiter A, Cochrane CG. Positive end-expiratory pressure during KL4 surfactant instillation enhances intrapulmonary distribution in a simian model of respiratory distress syndrome. Pediatric Research. 38: 211-217. PMID 7478818 DOI: 10.1203/00006450-199508000-00013 |
0.207 |
|
| 2005 |
Cochrane CG. Lucinactant in Neonatal Respiratory Distress Syndrome Treatments in Respiratory Medicine. 4: 146-147. DOI: 10.2165/00151829-200504020-00011 |
0.205 |
|
| 1987 |
Jackson JH, Schraufstatter IU, Hyslop PA, Vosbeck K, Sauerheber R, Weitzman SA, Cochrane CG. Role of oxidants in DNA damage. Hydroxyl radical mediates the synergistic DNA damaging effects of asbestos and cigarette smoke. The Journal of Clinical Investigation. 80: 1090-5. PMID 2821073 DOI: 10.1172/Jci113165 |
0.203 |
|
| 1974 |
Russell SW, Francke U, Buettner L, Cochrane CG. Modes of Growth and Spread of a Transplantable, Virus-Producing Murine (Moloney) Sarcoma: Karyotypic Analyses Journal of the National Cancer Institute. 53: 801-806. PMID 4414698 DOI: 10.1093/Jnci/53.3.801 |
0.181 |
|
| 1981 |
Marone G, Kagey-Sobotka A, Lichtenstein LM, Meier HL, Kaplan AP, Gershon RK, Dvorak AM, Galli SJ, Dvorak HF, Yunginger JW, Schröder H, Andrae M-, Yman L, Fischer B, Schmutzler W, ... ... Cochrane CG, et al. Contents, Vol. 66, Supplement 1, 1981 International Archives of Allergy and Immunology. 66. DOI: 10.1159/000232860 |
0.17 |
|
| Hide low-probability matches. |
